Investigation of IL-33 serum levels in patients with benign and malignant salivary gland tumors.

CONCLUSIONS: IL-33 could be suggested as a novel biomarker to distinguish different types of SGTs. PMID: 29991126 [PubMed - as supplied by publisher]
Source: Cancer Biomarkers - Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research